FDA Debuts List For Rapidly Announcing Noncompliant Ingredients In Supplements
FDA announces addition of Dietary Supplement Ingredient Advisory List page to its website to identify ingredients it has preliminary determined should be used in dietary supplements. It also publishes warning letters submitted recently to firms marketing supplements containing two ingredients agency has concluded should not be used: eight were warned about using an ingredient identified as "DMHA" and three about using phenibut.
You may also be interested in...
One or more of 5-alpha-hydroxy laxogenin, higenamine, hordenine and octopamine is used by 11 firms FDA warned in products labeled as supplements and marketed as beneficial for weight loss and strength training.
Hornedine isn’t an “old” dietary ingredient exempt from pre-market notification with proof its safety because it wasn’t available in the US food supply before October 1994. "T
Latest FDA warning to Chill6 doesn’t reference previous letter but lists larger number of violations along with more details about the problems. Agency also recently added salt scrub therapies to its list of products as marketed with fraudulent coronavirus treatment claims.